Table II.
Analyte | N | Odds Ratio | 95% CI | P-value |
---|---|---|---|---|
RDS | ||||
IL-6 >75th percentile | 400 | 0.88 | 0.36–2.14 | 0.79 |
CRP >75th percentile | 400 | 0.64 | 0.26–1.58 | 0.34 |
MPO >75th percentile | 399 | 0.50 | 0.20–1.21 | 0.12 |
CLD | ||||
IL-6 >75th percentile | 400 | 0.33 | 0.09–1.23 | 0.10 |
CRP >75th percentile | 400 | 0.10 | 0.02–0.41 | 0.002 |
MPO >75th percentile | 399 | 0.55 | 0.15–2.07 | 0.38 |
Sepsis | ||||
IL-6 >75th percentile | 400 | 0.52 | 0.14–1.99 | 0.34 |
CRP >75th percentile | 400 | 1.06 | 0.40–2.84 | 0.91 |
MPO >75th percentile | 399 | 0.77 | 0.20–2.93 | 0.70 |
NEC | ||||
IL-6 >75th percentile | 400 | 1.85 | 0.50–6.78 | 0.35 |
CRP >75th percentile | 400 | 1.60 | 0.47–5.41 | 0.45 |
MPO >75th percentile | 399 | 1.25 | 0.38–4.14 | 0.72 |
IVH | ||||
IL-6 >75th percentile | 387 | 1.00 | 0.31–3.19 | 1.00 |
CRP >75th percentile | 387 | 1.22 | 0.45–3.33 | 0.69 |
MPO >75th percentile | 386 | 1.29 | 0.44–3.73 | 0.64 |
The logistic regression analysis model included gestational age at delivery, treatment group and analytes. CI, confidence interval; CLD, chronic lung disease; CRP, C-reactive protein; IL-6,